Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(11/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(11/week)
News
United States
(530/week)
Manufacturing
(352/week)
Energy
(282/week)
Technology
(363/week)
Other Manufacturing
(284/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Heron Therapeutics Inc.
Jun 04, 2020
Heron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee Arthroplasty
May 18, 2020
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
Mar 02, 2020
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
Feb 19, 2020
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain
Feb 18, 2020
Heron Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Jan 13, 2020
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
Dec 16, 2019
Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain
Dec 03, 2019
Health Canada Grants Priority Review Status for Heron Therapeutics' New Drug Submission for HTX-011 for Management of Postoperative Pain
Nov 14, 2019
Heron Therapeutics to Present at the Jefferies London Healthcare Conference
Nov 12, 2019
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Updates
Oct 28, 2019
Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain
Oct 22, 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC)
Oct 03, 2019
Heron Therapeutics Announces Proposed Public Offering of Common Stock
Oct 01, 2019
Heron Therapeutics Appoints Kimberly Manhard to Board of Directors
Oct 01, 2019
Heron Therapeutics Appoints Stephen Davis to Board of Directors
Oct 01, 2019
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Management of Postoperative Pain
Aug 05, 2019
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Updates
Jul 12, 2019
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
Jun 17, 2019
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX
Jun 13, 2019
Heron Therapeutics to Present at 2019 JMP Securities Life Sciences Conference
Page 1
››
Latest News
Apr 20, 2024
Biloxi Marsh Lands Corporation Announces Unaudited Results for the First Quarter of 2024
Apr 20, 2024
Evergy Schedules Conference Call to Discuss 1st Quarter Results
Apr 20, 2024
Stem Announces Appointment of AI Industry Leader as New Independent Director
Apr 20, 2024
Clarification of Details Regarding Oceansix's Engagement with RB Milestone Group LLC
Apr 20, 2024
Eaton to announce first quarter 2024 earnings on April 30, 2024
Apr 20, 2024
Permianville Royalty Trust Announces Monthly Operational Update
Apr 20, 2024
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Apr 20, 2024
nVent Electric plc to Release First Quarter 2024 Financial Results and Host Earnings Conference Call on...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events